Impairment of NEK1 kinase function is sufficient to trigger ALS

While mutations in the NEK1 gene leading to a loss of the protein were previously the primary known cause of…

Read more

Final push!

The University Hospital of Neurology in Ulm is currently conducting a placebo-controlled study on the efficacy of a high-calorie, high-fat…

Read more

A New Chapter in Clinical ALS Research begins in Ulm

The successful conclusion of the agreement to conduct an innovative clinical trial marks an important milestone. The trial will evaluate…

Read more

Major EU survey on medical care for ALS patients

The ERN EURO-NMD, an EU-initiated and funded disease network, is developing a European care pathway for people with ALS as…

Read more

The Ulm ALS Center is part of an award-winning international consortium dedicated to developing ALS therapies using artificial intelligence

We are pleased to officially announce that the ALS Center Ulm is one of the 20 winning teams of the…

Read more

What is ALS.live?

ALS.live is an information and exchange platform of the ALS Center and ALS research activities in Ulm.

Our goal is to provide people living with amyotrophic lateral sclerosis (ALS), their families, healthcare professionals, and other interested audiences with clear and accessible information about ALS and ALS-related activities in Ulm.

  • Up-to-date research findings directly from ALS research
  • Articles in which experts from medicine and science share their knowledge and insights
  • An overview and explanation of the diverse ALS research and care structures in Ulm

The platform is intended as a bridge between scientific research, highly specialized care, and the everyday lives of people with ALS—transparent, accessible, and closely aligned with the needs of those affected.

ALS in Ulm

Clinical Care

Therapies

Research